Vanguard Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.1K | Hold |
|
|||||
|
2025
Q1 | $34.9K | Sell |
|
|||||
|
2024
Q4 | $178K | Sell |
|
|||||
|
2024
Q3 | $347K | Hold |
|
|||||
|
2024
Q2 | $511K | Buy |
|
|||||
|
2024
Q1 | $791K | Sell |
|
|||||
|
2023
Q4 | $389K | Hold |
|
|||||
|
2023
Q3 | $285K | Hold |
|
|||||
|
2023
Q2 | $2.93M | Sell |
|
|||||
|
2023
Q1 | $4.71M | Hold |
|
|||||
|
2022
Q4 | $2.34M | Buy |
|
|||||
|
2022
Q3 | $6.31M | Hold |
|
|||||
|
2022
Q2 | $3.94M | Buy |
|
|||||
|
2022
Q1 | $4.78M | Sell |
|
|||||
|
2021
Q4 | $5.72M | Sell |
|
|||||
|
2021
Q3 | $4.73M | Buy |
|
|||||
|
2021
Q2 | $5.37M | Buy |
|
|||||
|
2021
Q1 | $5.1M | Buy |
|
|||||
|
2020
Q4 | $5.86M | Buy |
|
|||||
|
2020
Q3 | $20.3M | Sell |
|
|||||
|
2020
Q2 | $15.2M | Buy |
|
|||||
|
2020
Q1 | $5.64M | Buy |
|
|||||
|
2019
Q4 | $3.3M | Buy |
|
|||||
|
2019
Q3 | $2.99M | Buy |
|
|||||
|
2019
Q2 | $2.73M | Hold |
|
|||||
|
2019
Q1 | $3M | Buy |
|
|||||
|
2018
Q4 | $2.44M | Sell |
|
|||||
|
2018
Q3 | $2.65M | Hold |
|
|||||
|
2018
Q2 | $2.71M | Buy |
|
|||||
|
2018
Q1 | $2.14M | Buy |
|
|||||
|
2017
Q4 | $2.66M | Buy |
|
|||||
|
2017
Q3 | $2.79M | Buy |
|
|||||
|
2017
Q2 | $2.73M | Buy |
|
|||||
|
2017
Q1 | $2.72M | Buy |
|
|||||
|
2016
Q4 | $1.48M | Buy |
|
|||||
|
2016
Q3 | $1.36M | Buy |
|
|||||
|
2016
Q2 | $1.19M | Buy |
|
|||||
|
2016
Q1 | $1.3M | Buy |
|
|||||
|
2015
Q4 | $1.32M | Buy |
|
|||||
|
2015
Q3 | $1.03M | Buy |
|
|||||
|
2015
Q2 | $1.51M | Buy |
|
|||||
|
2015
Q1 | $1.44M | Buy |
|